pre-update Archives

Blog

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…

Certara2020年8月7日

Publication

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…

Certara2020年7月26日

Publication

Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19

We hypothesized that viral kinetic modeling could be helpful to prioritize rational drug combinations for…

Certara2020年7月26日

Article

PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue

Certara2020年7月20日

Publication

Salvaging CNS Clinical Trials Halted Due to COVID‐19

The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical…

Certara2020年7月15日

Blog

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

3 key tips to set your pediatric program up for success with the RACE for…

Certara2020年7月14日

Publication

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…

Certara2020年7月14日

SDTM Supplemental Qualifiers - blog post by Certara

On-Demand Webinar

The supplementary domain in SDTM: good, bad and ugly

All you need to know about the supplementary domain in SDTM The supplementary domain in…

Certara2020年7月2日

Publication

VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays

Certara2020年6月28日

On-Demand Webinar

Simcyp：20年に渡るイノベーションの軌跡

Certara2020年6月27日

Powered by Translations.com GlobalLink Web Software

pre-update

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm

Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19

PharmaTimes: Interview with Demetrius Carter, The Future is Diversity Issue

Salvaging CNS Clinical Trials Halted Due to COVID‐19

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology

The supplementary domain in SDTM: good, bad and ugly

VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assays

Simcyp：20年に渡るイノベーションの軌跡

メルマガ登録

クイックアクセス

ソリューション

お問合せ